Khalid Z. Al Shali MBChB (Hon), M.Sc., ABIM, ABEM, FRCP(C), FACP

Professor and Consultant, Endocrinology
Diabetes and Endocrine Centre of Excellence

20 Years of Experience

Languages:

English
Arabic

Education

1994 Medical School

Bachelor’s Degree in Medicine and Surgery

King Abdulaziz University in Jeddah, KSA

2004 Medical School

Master’s Degree in Biochemistry

University of Western Ontario, Canada

1997 - 2000 Residency

Residency: Internal Medicine,

University of Western Ontario (UWO)

Fellowships

2000 - 2002 Fellowship

Fellowship Endocrinology and Metabolism

University of Western Ontario (UWO)

2002 - 2004 Fellowship

strategic training fellow in vascular research

Canadian Institutes of Health Research (CIHR)

Work Experience

2007 - Present

Consultant, Endocrinology

International Medical Centre in Jeddah, KSA

2017 - Present

Professor of Medicine and Endocrinology

King Abdulaziz University, KSA

2000

Internal medicine

American Board

Endocrinology diabetes and metabolism

American Board

Achievements & Career Highlights

Consultant endocrinologist since 2004.
Professor of Medicine and Endocrinology since 2021.
American Board Internal Medicine certified in 2000.
Royal College of Physicians and Surgeons of Canada Internal Medicine certified in 2001.
Fellow of the Royal College of Physicians and Surgeons of Canada in the division of Medicine since 2001.
American Board Endocrinology certified in 2002.
Royal College of Physicians and Surgeons of Canada Endocrinology certified in 2002.
Fellow of the American College of Physicians, 2004.
Program Director of the SCHS Diabetes Subspecialty Fellowship Program at King Abdulaziz University Hospital from March 2018 to present

Publications

Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. Clin Biochem. 2002 Mar;35(2):125-130.
Management of severe hypertriglyceridemia in pregnancy. University of Western Ontario Medical Journal. 2003; 72(2):12-14.
Laminopathies and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1591-5.
Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke. 2004 Sep; 35(9):2036-40.
A single base mutation in the PPAR?4 promoter associated with altered in vitro expression and partial lipodystrophy. J Clin Endocrinol Metab. 2004 Nov;89(11):5655-60.
Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007 Apr 10;176(8):1113-20
Iodine Deficiency Among Hypothyroid Patients Living in Jeddah. Biol Trace Elem Res. 2009, 130: 193-203.
Prevalence of hyper- and hypoglycemia among adult inpatients at a university hospital in Saudi Arabia. Journal of King Abdulaziz University – Medical Sciences. 2014. Volume 21 (4), 25-37.
A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily inthe treatment of type 2 diabetes. Saudi Med J. 2016 Aug; 37(8):834-42.
The covariant CDKN2A/B rs10811661 (C/T) gene polymorphism is associated with increased risk of type 2 diabetes mellitus in a Saudi Arabian population. Middle East Journal of Medical Genetics. 2018,7:19–25.
Association between type 2 diabetes mellitus and hypothyroidism: a case-control study. Int J Gen Med. 2018 Dec 4;11:457-461.
Knowledge, Attitudes, and Practices of COVID-19 Safety Measures Among Type 1 Diabetes Mellitus Patients at King Abdulaziz University Hospital: A Cross-Sectional Study. Cureus 2022. 14(8): e27713.
Clinical Practice Guideline for the Management of Overweight and Obesity in Adults in Saudi Arabia. International Journal of Clinical Medicine, 2022. 13, 590-649.
Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit. Adv Ther. 2023. 40:2965–2984